These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34668889)

  • 41. In utero hematopoietic stem cell transplantation and gene therapy.
    Crombleholme TM; Bianchi DW
    Semin Perinatol; 1994 Aug; 18(4):376-84. PubMed ID: 7985048
    [No Abstract]   [Full Text] [Related]  

  • 42. In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of beta-glucuronidase can delay onset of clinical signs.
    Casal ML; Wolfe JH
    Blood; 2001 Mar; 97(6):1625-34. PubMed ID: 11238101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of CD 34(+) mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates.
    Shields LE; Gaur L; Delio P; Gough M; Potter J; Sieverkropp A; Andrews RG
    J Med Primatol; 2005 Aug; 34(4):201-8. PubMed ID: 16053498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In utero stem cell transplantation.
    Flake AW
    Best Pract Res Clin Obstet Gynaecol; 2004 Dec; 18(6):941-58. PubMed ID: 15582548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Future of In Utero Gene Therapy.
    Peranteau WH; Flake AW
    Mol Diagn Ther; 2020 Apr; 24(2):135-142. PubMed ID: 32020561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CRISPR/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation.
    Daniel-Moreno A; Lamsfus-Calle A; Raju J; Antony JS; Handgretinger R; Mezger M
    Bone Marrow Transplant; 2019 Dec; 54(12):1940-1950. PubMed ID: 30903024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fetal therapy: prospects for transplantation early in pregnancy. In utero stem cell transplantation and gene therapy: second international meeting, Nottingham, UK, 1-2 September 1997.
    Jones DR; Bui TH
    Mol Med Today; 1998 Jan; 4(1):10-1. PubMed ID: 9494961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Persistence of CRISPR/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta-analysis of preclinical studies.
    Maganti HB; Bailey AJM; Kirkham AM; Shorr R; Pineault N; Allan DS
    Stem Cells Transl Med; 2021 Jul; 10(7):996-1007. PubMed ID: 33666363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.
    Hayashi S; Peranteau WH; Shaaban AF; Flake AW
    Blood; 2002 Aug; 100(3):804-12. PubMed ID: 12130490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ethical issues in the diagnosis and management of fetal disorders.
    Chadwick R; Childs R
    Best Pract Res Clin Obstet Gynaecol; 2012 Oct; 26(5):541-50. PubMed ID: 22901734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stem cell transplantation in the fetus.
    Muench MO; Bárcena A
    Cancer Control; 2004; 11(2):105-18. PubMed ID: 15024347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal stem cell transplantation and gene therapy.
    Santore MT; Roybal JL; Flake AW
    Clin Perinatol; 2009 Jun; 36(2):451-71, xi. PubMed ID: 19559331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Why do in utero stem cell transplants sometimes fail?
    Jones DR
    Mol Med Today; 1999 Jul; 5(7):288-91. PubMed ID: 10377519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In utero stem cell transplantation.
    Monni G; Ibba RM; Zoppi MA; Floris M
    Croat Med J; 1998 Jun; 39(2):220-3. PubMed ID: 9575281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic stem cell transplantation for treatment of immunodeficiency.
    Friedrich W; Müller SM
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):109-18. PubMed ID: 15368077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with Mucopolysaccharidosis type VII.
    Nguyen QH; Witt RG; Wang B; Eikani C; Shea J; Smith LK; Boyle G; Cadaoas J; Sper R; MacKenzie JD; Villeda S; MacKenzie TC
    Sci Transl Med; 2020 Feb; 12(532):. PubMed ID: 32102934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Joy of Discovery: The Birth of Fetal Surgery and the Path to In Utero Stem Cell Therapy.
    Farmer DL
    Ann Surg; 2023 Sep; 278(3):301-309. PubMed ID: 37325918
    [No Abstract]   [Full Text] [Related]  

  • 58. Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency.
    Westgren M; Ringdén O; Bartmann P; Bui TH; Lindton B; Mattsson J; Uzunel M; Zetterquist H; Hansmann M
    Am J Obstet Gynecol; 2002 Aug; 187(2):475-82. PubMed ID: 12193946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In utero cellular therapy].
    Forestier F
    Contracept Fertil Sex; 1997 Jun; 25(6):I-IV. PubMed ID: 9280542
    [No Abstract]   [Full Text] [Related]  

  • 60. CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications.
    Venkatesan V; Christopher AC; Karuppusamy KV; Babu P; Alagiri MKK; Thangavel S
    J Vis Exp; 2022 Aug; (186):. PubMed ID: 36036597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.